AD Woolfson

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Background With an effective vaccine being sought for the prevention of HIV transmission, current focus is upon a mucosal vaccine strategy providing protection at the viral point of entry. The full potential of these vaccines can only be realised with the development of successful delivery systems which are also capable of providing an environment conducive(More)
  • RJ Morrow, L Donnelly, +4 authors R Shattock
  • Retrovirology
  • 2009
Background Cervicovaginal (CV) tissue is the primary site for HIV transmission and a major reservoir for viral replication. Therefore, a successful vaccine strategy should induce potent immune responses at this mucosal surface. One potential method for achieving a localised immune response is to administer the antigen directly to the CV tissue (Marx et al.,(More)
  • 1